[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]. / Sravnitel'noe platsebo-kontroliruemoe klinicheskoe issledovanie effektivnosti i bezopasnosti preparatov glatiramera atsetata 20 mg u patsientov s remittiruyushchim rasseyannym sklerozom: rezul'taty pervogo goda nablyudeniya.
Zh Nevrol Psikhiatr Im S S Korsakova
; 116(10 Pt 2): 61-67, 2016.
Article
in Ru
| MEDLINE
| ID: mdl-28139613
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Glatiramer Acetate
/
Immunosuppressive Agents
Type of study:
Clinical_trials
Limits:
Humans
Language:
Ru
Journal:
Zh Nevrol Psikhiatr Im S S Korsakova
Journal subject:
NEUROLOGIA
/
PSIQUIATRIA
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: